Atrial fibrillation

Chiv, R., Beradid, S., Suissa, S., & Renoux, C. (2024). Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study. Stroke. http://doi.org/10.1161/strokeaha.123.045098
Liaw, J., Liaw, D., & Dave, C. (2024). Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020. Open Heart, 11. http://doi.org/10.1136/openhrt-2023-002515
Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C., Morris, C., et al. (2023). Oral anticoagulant prescribing among patients with cancer and atrial fibrillation in England, 2009-2019. Cancer. http://doi.org/10.1002/cncr.35152
Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C., Morris, C., et al. (2023). Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Study in England. J Am Heart Assoc, 12, e029423. http://doi.org/10.1161/jaha.123.029423
Apenteng, P. N., Prieto-Merino, D., Hee, S. W., Lobban, T. C., Caleyachetty, R., & Fitzmaurice, D. A. (2023). Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records. Br J Gen Pract, 73, e816-e824. http://doi.org/10.3399/bjgp.2023.0082
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Wilkinson, C., Cowan, J. C., et al. (2023). Temporal trends of cause-specific mortality after diagnosis of atrial fibrillation. Eur Heart J. http://doi.org/10.1093/eurheartj/ehad571
Mendonca, S. C., Edwards, D. A., Lund, J., Saunders, C. L., & Mant, J. (2023). Progression of stroke risk in patients aged <65 years diagnosed with atrial fibrillation: a cohort study in general practice. Br J Gen Pract. http://doi.org/10.3399/bjgp.2022.0568
Wu, J., Nadarajah, R., Nakao, Y. M., Nakao, K., Hogg, D., Raveendra, K., et al. (2023). Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study. Open Heart, 10. http://doi.org/10.1136/openhrt-2023-002357
Nadarajah, R., Wu, J., Hogg, D., Raveendra, K., Nakao, Y. M., Nakao, K., et al. (2023). Prediction of short-term atrial fibrillation risk using primary care electronic health records. Heart. http://doi.org/10.1136/heartjnl-2022-322076
Rahman, A., Michaud, J., Dell'Aniello, S., Moodie, E. E. M., Brophy, J. M., Durand, M., et al. (2022). Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study. Neurology. http://doi.org/10.1212/wnl.0000000000206748